22Dec
Cadent Therapeutics Acquired by Novartis for Up to $770 Million
Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the treatment of cognitive, mood, and movement disorders, announced on December 17, 2020, that Novartis will acquire all of the outstanding capital stock of Cadent Therapeutics....
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
Gainesville Mech., Inc. v. Air Data, Inc., No. A19A0518., 2019 BL 229069 (Ga. Ct. App. June 19, 2019...
Read More >
The Internal Revenue Service (IRS), in a recently released memorandum from the Office of Chief Couns...
Read More >
On June 3, 2019, the SEC’s Office of the Whistleblower announced a $3 million award to two whistleb...
Read More >
Last week, the IRS issued it updated Form 1094-C and 1095-C instructions for 2019. Employers that em...
Read More >
New York Governor Andrew Cuomo signed into law yesterday a bill which will dramatically alter the wa...
Read More >
What does an age discrimination plaintiff have to prove to succeed? Federal employees may have an ea...
Read More >